Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sutro Biopharma (STRO) Return on Assets (2018 - 2025)

Historic Return on Assets for Sutro Biopharma (STRO) over the last 8 years, with Q3 2025 value amounting to 0.87%.

  • Sutro Biopharma's Return on Assets fell 6100.0% to 0.87% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87%, marking a year-over-year decrease of 6100.0%. This contributed to the annual value of 0.53% for FY2024, which is 2900.0% down from last year.
  • As of Q3 2025, Sutro Biopharma's Return on Assets stood at 0.87%, which was down 6100.0% from 0.68% recorded in Q2 2025.
  • Sutro Biopharma's 5-year Return on Assets high stood at 0.18% for Q2 2021, and its period low was 0.87% during Q3 2025.
  • For the 5-year period, Sutro Biopharma's Return on Assets averaged around 0.37%, with its median value being 0.31% (2022).
  • Its Return on Assets has fluctuated over the past 5 years, first surged by 1800bps in 2021, then plummeted by -6100bps in 2025.
  • Sutro Biopharma's Return on Assets (Quarter) stood at 0.27% in 2021, then fell by -11bps to 0.3% in 2022, then increased by 20bps to 0.24% in 2023, then tumbled by -129bps to 0.54% in 2024, then crashed by -61bps to 0.87% in 2025.
  • Its last three reported values are 0.87% in Q3 2025, 0.68% for Q2 2025, and 0.66% during Q1 2025.